Hongyuan Yu

Nanjing Street 155
Shenyang, 110001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune microenvironment remodeling in prostate cancer progression.

Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune microenvironment remodeling in prostate cancer progression.

Journal: Molecular cancer
Published: November 17, 2025

ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancer.

ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancer.

Journal: Colloids and surfaces. B, Biointerfaces
Published: September 30, 2025

Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer.

Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer.

Journal: Materials today. Bio
Published: September 13, 2025

The Impact of METTL3 on MDM2 Promotes Podocytes Injury During Diabetic Kidney Disease.

The Impact of METTL3 on MDM2 Promotes Podocytes Injury During Diabetic Kidney Disease.

Journal: Journal of cellular and molecular medicine
Published: October 22, 2024

Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K/Akt/mTOR pathway and enhancing AR-V7 alternative splicing.

Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K/Akt/mTOR pathway and enhancing AR-V7 alternative splicing.

Journal: Cell death & disease
Published: July 08, 2024

N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1.

N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1.

Journal: BMC biology
Published: January 08, 2024

GLIS1 alleviates cell senescence and renal fibrosis through PGC1-α mediated mitochondrial quality control in kidney aging.

GLIS1 alleviates cell senescence and renal fibrosis through PGC1-α mediated mitochondrial quality control in kidney aging.

Journal: Free radical biology & medicine
Published: August 07, 2023

ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.

ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.

Journal: BMC cancer
Published: June 18, 2022

Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.

Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.

Journal: Oxidative medicine and cellular longevity
Published: May 16, 2022

SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.

SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.

Journal: Journal of cellular and molecular medicine
Published: October 01, 2020

Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.

Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.

Journal: Cancer management and research
Published: July 26, 2020

LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.

LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.

Journal: Cancer biomarkers : section A of Disease markers
Published: January 21, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026